Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

OnabotulinumtoxinA is being increasingly used in the management of chronic migraine (CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional therapy with orally administered preventatives. The European Headache Federation identified an expert group that was asked to develop...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Headache Pain
Asıl Yazarlar: Bendtsen, Lars, Sacco, Simona, Ashina, Messoud, Mitsikostas, Dimos, Ahmed, Fayyaz, Pozo-Rosich, Patricia, Martelletti, Paolo
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Milan 2018
Konular:
Consensus Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6755553/
https://ncbi.nlm.nih.gov/pubmed/30259200
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s10194-018-0921-8
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller